Blog Archives

DEA assigns Schedule V status to cannabis-based Epidiolex!

DEA assigns Schedule V status to cannabis-based Epidiolex! Here’s an update everybody into the medical cannabis community happens to be awaiting: the U.S. Drug Enforcement Administration has offered Today cannabis-derived drug Epidiolex a Schedule V classification. This is basically the time that is first cannabis-based medication happens to be rescheduled in the usa. What exactly is Epidiolex, precisely? Epidiolex can be a prescription that is oral manufactured by U.K.-based GW Pharmaceuticals PLC. It had been formulated to deal with two…
Posted in Cbd Oil Global Inc
Sign up for our newsletter!

The Book
TSS Image
Archives